Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


P&G launches online shopping portal

This article was originally published in The Tan Sheet

Executive Summary

Procter & Gamble formally introduces its shopping Web site to U.S. consumers May 20. sells P&G branded products including Olay and Crest. The site is a "learning lab" for e-commerce innovation, the firm said. It "will help [P&G] listen, learn and collaborate with online shoppers to find new opportunities to serve consumers' household, beauty and grooming needs," said Kirk Perry, P&G's VP North America. The site features "brand shop" pages for P&G brands, "making shopping for products more intuitive and helping shoppers make the perfect product selections for their needs," P&G said. The site also allows live chats with P&G consultants, social media integration, a forum for shopper feedback and $5 standard shipping. It soon will include a compatible mobile phone application. The eStore, which launched as a test version in January, potentially could compete against online retailers already selling P&G brands (1"The Tan Sheet" May 10, 2010)

You may also be interested in...

Web Ripe For Growing OTC, Supplement Ads As More Consumers Shop Online

Firms can capitalize on the rising number of consumers shopping online for OTC drugs and vitamins by increasing Internet marketing that highlights convenience, privacy and bargains, experts and industry leaders say

More GMP Warnings, Import Alerts For OTC Firms As US FDA Capped List Of Uninspected Facilities

Most of the foreign OTC drug firms targeted in latest warnings FDA published, including the GUM oral care brand manufacturer, were placed on import alert due to GMP violations. Each was inspected by FDA during June, July or May 2019, when the agency was wrapping up an initiative to inspect all previously uninspected drug manufacturers.

AbbVie/Allergan Merger Edges Closer To FTC Clearance

AstraZeneca will reacquire Allergan's investigational IL-23 inhibitor brazikumab, and Nestle is to buy its GI drug Zenpep, which had nine-month revenue of $208m.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts